Breast Cancer Therapeutics Market trends research and projections for 2017-2024

1
Breast Cancer Therapeutics Market to surpass
28Bn by 2024 Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Breast Cancer Therapeutics
Market

• U.S. breast cancer therapeutics market accounted
  for largest business share in 2016 and is
  anticipated to grow substantially over the
  forecast period. Increases access to breast
  cancer screening, diagnosis and treatment
  services will be the chief growth rendering
  factor. Moreover, increasing adoption of therapy
  drug by patients will fuel regional business
  growth.
• Rising incidence of disease due to increasing
  exposure to factors such as use of hormone
  replacement therapy (HRT), lifestyle related
  factors such as alcohol consumption, obesity and
  alteration in family size which stimulates the
  usage rate of therapeutics over the forecast
  period will propel the industry growth.
• China should witness considerable growth in the
  coming years due to increase in awareness
  programs to spread alertness regarding breast
  cancer screening, robust economic growth and
  rising disposable income.

3
Continued...

• Brazil breast cancer therapeutics market is
  projected to grow at a significant CAGR over the
  forecast period. Increased life expectancy among
  individuals and healthcare facility development
  are the chief features driving breast cancer
  therapeutics market growth in the country.
• Some of the companies operating in breast cancer
  therapeutics market are Roche Diagnostics,
  Pfizer, AstraZeneca, Novartis, Sanofi, Eisai, and
  Eli Lily. New product launches, strong product
  pipeline, geographical expansion, mergers and
  acquisition will mainly boost the business. Chief
  industry players will endeavor to strengthen
  their place in this competitive market by
  implementation these strategies.

4
U.S. Breast Cancer Therapeutics Market, By
Product, 2013 - 2024 (USD Billion)

5

Browse Full Market Research Report On
Bioreactor Market _at_ https//goo.gl/1aWif9 Request
for a Sample of this Research Report
_at_ https//www.gminsights.com/request-sample/detail
/466
6
360 Analysis

• Application Trends
• Retail pharmacies held the largest market share
  in 2016 and will continue to be the biggest
  distribution channel for the industry over the
  forecast period. Growing shift from specialty to
  retail pharmacies owing to reimbursement
  variations and prolonged usage of oral
  formulations, particularly for targeted drug
  therapies will drive the business growth.
• Regional Trends
• U.S. breast cancer therapeutics market accounted
  for the highest regional share in 2016 due to
  growing prevalence of breast cancer and
  increasing RD funding through public and private
  sectors. Growing elderly population, breast
  feeding discontinuation at an early stage and
  increased access to cancer care will stimulate
  industry growth. Moreover, rising demand for
  tumor therapeutics will strongly drive industry
  growth in the country.
• Competitive Market Share
• Some of the major players in global breast cancer
  therapeutics market are AstraZeneca, Roche
  Diagnostics, Pfizer, Novartis, Eisai, Eli Lilly,
  Sanofi, and Celgene. Roche holds the largest
  market share owing to wide geographical presence
  and strong product portfolio. It is expected to
  dominate the industry revenue over the coming
  years. The company should face intense
  competition from other players such as
  AstraZeneca and Pfizer over the forecast years.

7
Stay In Touch Website www.gminsights.com Soci
al Media